Development of an adverse outcome pathway network for nephrotoxicity.
D A BarnesJames W FirmanSamuel J BelfieldMark T D CroninMathieu VinkenManoe J JanssenRosalinde MasereeuwPublished in: Archives of toxicology (2024)
Adverse outcome pathways (AOPs) were introduced in modern toxicology to provide evidence-based representations of the events and processes involved in the progression of toxicological effects across varying levels of the biological organisation to better facilitate the safety assessment of chemicals. AOPs offer an opportunity to address knowledge gaps and help to identify novel therapeutic targets. They also aid in the selection and development of existing and new in vitro and in silico test methods for hazard identification and risk assessment of chemical compounds. However, many toxicological processes are too intricate to be captured in a single, linear AOP. As a result, AOP networks have been developed to aid in the comprehension and placement of associated events underlying the emergence of related forms of toxicity-where complex exposure scenarios and interactions may influence the ultimate adverse outcome. This study utilised established criteria to develop an AOP network that connects thirteen individual AOPs associated with nephrotoxicity (as sourced from the AOP-Wiki) to identify several key events (KEs) linked to various adverse outcomes, including kidney failure and chronic kidney disease. Analysis of the modelled AOP network and its topological features determined mitochondrial dysfunction, oxidative stress, and tubular necrosis to be the most connected and central KEs. These KEs can provide a logical foundation for guiding the selection and creation of in vitro assays and in silico tools to substitute for animal-based in vivo experiments in the prediction and assessment of chemical-induced nephrotoxicity in human health.
Keyphrases
- human health
- risk assessment
- oxidative stress
- drug induced
- chronic kidney disease
- climate change
- diabetic rats
- molecular docking
- heavy metals
- working memory
- adverse drug
- dna damage
- high throughput
- end stage renal disease
- network analysis
- induced apoptosis
- ischemia reperfusion injury
- endoplasmic reticulum stress
- stress induced